Search Results

Dirithromycin 200 mg  | 99.59%

TargetMol

Dirithromycin is a macrolide glycopeptide antibiotic. It is used to treat many different types of bacterial infections, such as bronchitis, pneumonia, tonsillitis, and even skin infections.

More Information Supplier Page

Trimetazidine dihydrochloride 100 mg  | Purity Not Available

TargetMol

Trimetazidine dihydrochloride can improve myocardial glucose utilization by inhibiting fatty acid metabolism. Trimetazidine is the first cytoprotective anti-ischemic agent, also used as a vasodilator in ischemic heart disease or angina.

More Information Supplier Page

Roflumilast 25 mg  | 99.64%

TargetMol

Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3′, 5′-adenosine monophosphate (cAMP) and cAMP-mediated signaling.

More Information Supplier Page

Roflumilast 50 mg  | 99.64%

TargetMol

Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3′, 5′-adenosine monophosphate (cAMP) and cAMP-mediated signaling.

More Information Supplier Page

Roflumilast 5 mg  | 99.64%

TargetMol

Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3′, 5′-adenosine monophosphate (cAMP) and cAMP-mediated signaling.

More Information Supplier Page

Azilsartan 100 mg  | 99.87%

TargetMol

Azilsartan is an Angiotensin 2 Receptor Blocker. The mechanism of action of azilsartan is as an Angiotensin 2 Type 1 Receptor Antagonist. The physiologic effect of azilsartan is by means of Decreased Blood Pressure.

More Information Supplier Page

Azilsartan 50 mg  | 99.87%

TargetMol

Azilsartan is an Angiotensin 2 Receptor Blocker. The mechanism of action of azilsartan is as an Angiotensin 2 Type 1 Receptor Antagonist. The physiologic effect of azilsartan is by means of Decreased Blood Pressure.

More Information Supplier Page

Repaglinide 200 mg  | Purity Not Available

TargetMol

Repaglinide is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.

More Information Supplier Page

Repaglinide 50 mg  | Purity Not Available

TargetMol

Repaglinide is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.

More Information Supplier Page

Mianserin hydrochloride 100 mg  | 99.63%

TargetMol

Mianserin hydrochloride is a tetracyclic compound with antidepressant effects. it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. It may cause drowsiness and hematological problems.

More Information Supplier Page